Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Dexamethasone could be more effective than prednisolone at similar anti-inflammatory doses in the treatment of childhood acute lymphoblastic leukemia. In order to check if this “superiority” of dexamethasone might be dose-dependent, we conducted a randomized phase III trial comparing dexamethasone (...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Carine Domenech, Stefan Suciu, Barbara De Moerloose, Françoise Mazingue, Geneviève Plat, Alina Ferster, Anne Uyttebroeck, Nicolas Sirvent, Patrick Lutz, Karima Yakouben, Martine Munzer, Pierre Röhrlich, Dominique Plantaz, Frederic Millot, Pierre Philippet, Nicole Dastugue, Sandrine Girard, Hélène Cavé, Yves Benoit, Yves Bertrandfor, Children’s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC)
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Ferrata Storti Foundation 2014-07-01
Colecção:	Haematologica
Acesso em linha:	https://haematologica.org/article/view/7087
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!